MedicaidPrior AuthMedium impact
Palonosetron IV (Aloxi generics) (Revised)
Humana·OH · Oncology, Anesthesiology, General Surgery·Medicaid
Effective date
Jan 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicaid Ohio has implemented a new prior authorization policy for Palonosetron IV (generic Aloxi) used for chemotherapy-induced and post-operative nausea/vomiting prevention and treatment. The policy establishes specific age-based criteria and approval durations for different indications.
Action Required
By January 1, 2026: Billing team must update prior authorization requirements for Palonosetron IV (generic Aloxi) claims for Ohio Medicaid patients. Providers must obtain prior auth by documenting patient age, indication (CINV prevention/treatment or PONV prevention/treatment), chemotherapy regimen type per NCCN guidelines, and treatment duration. Visit www.humana.com/PAL for specific medical billing codes. Claims without proper prior authorization will be denied.